Jennifer Johnston, PhD, Chairs First CNS Degrader Meeting on Oct 30th in Boston
San Francisco | October 20, 2023 – Dr. Johnston’s team has been working on the identification of small molecule modulators of the E3 ubiquitin ligase, Parkin, for the last 18 years.
FinsnoBio and Accelero Biostructures Announce Partnership for X-Ray Crystallography Drug Discovery
In conjunction with the BIO 2021 conference, Snøhamer Group and FinsnoBio proudly announce a new drug discovery partnership with the world’s leading x-ray crystallography enterprise Accelero Biostructures. FinsnoBio, sister to gene-therapy company NysnoBio, works to